{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "![JohnSnowLabs](https://nlp.johnsnowlabs.com/assets/images/logo.png)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import json\n",
    "import os\n",
    "license_key = \"/home/ubuntu/damla/keys/4.1.0.spark_nlp_for_healthcare.json\"\n",
    "with open( license_key) as f:\n",
    "    license_keys = json.load(f)\n",
    "    \n",
    "# Defining license key-value pairs as local variables\n",
    "locals().update(license_keys)\n",
    "\n",
    "# Adding license key-value pairs to environment variables\n",
    "os.environ.update(license_keys)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Spark NLP Version : 4.1.0\n",
      "Spark NLP_JSL Version : 4.1.0\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "            <div>\n",
       "                <p><b>SparkSession - in-memory</b></p>\n",
       "                \n",
       "        <div>\n",
       "            <p><b>SparkContext</b></p>\n",
       "\n",
       "            <p><a href=\"http://ip-172-31-38-169.us-east-2.compute.internal:4040\">Spark UI</a></p>\n",
       "\n",
       "            <dl>\n",
       "              <dt>Version</dt>\n",
       "                <dd><code>v3.1.2</code></dd>\n",
       "              <dt>Master</dt>\n",
       "                <dd><code>local[*]</code></dd>\n",
       "              <dt>AppName</dt>\n",
       "                <dd><code>Spark NLP Licensed</code></dd>\n",
       "            </dl>\n",
       "        </div>\n",
       "        \n",
       "            </div>\n",
       "        "
      ],
      "text/plain": [
       "<pyspark.sql.session.SparkSession at 0x7f2b1445cb00>"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import json\n",
    "import os\n",
    "from pyspark.ml import Pipeline,PipelineModel\n",
    "from pyspark.sql import SparkSession\n",
    "from pyspark.sql import functions as F\n",
    "\n",
    "from sparknlp.annotator import *\n",
    "from sparknlp_jsl.annotator import *\n",
    "from sparknlp.base import *\n",
    "import sparknlp_jsl\n",
    "import sparknlp\n",
    "\n",
    "from sparknlp_display import NerVisualizer\n",
    "\n",
    "import warnings\n",
    "warnings.filterwarnings('ignore')\n",
    "\n",
    "params = {\"spark.driver.memory\":\"16G\", \n",
    "          \"spark.kryoserializer.buffer.max\":\"2000M\", \n",
    "          \"spark.driver.maxResultSize\":\"2000M\"} \n",
    "\n",
    "print (\"Spark NLP Version :\", sparknlp.version())\n",
    "print (\"Spark NLP_JSL Version :\", sparknlp_jsl.version())\n",
    "\n",
    "spark = sparknlp_jsl.start(license_keys['SECRET'],params=params)\n",
    "\n",
    "spark"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {},
   "outputs": [],
   "source": [
    "text_list = [\n",
    "\"\"\"Efficacy and safety of vildagliptin in patients with type 2 diabetes mellitus inadequately controlled with dual combination of metformin and sulphonylurea . This study assessed the efficacy and safety of vildagliptin as add - on therapy to metformin plus glimepiride combination in patients with type 2 diabetes mellitus ( T2DM ) who had inadequate glycaemic control . A multicentre , double - blind , placebo - controlled study randomized patients to receive treatment with vildagliptin 50   mg bid or placebo for 24   weeks .\"\"\",\n",
    "\"\"\"Randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type 2 diabetes. In a multicentre, open, randomised study, 570 patients with Type 2 diabetes, aged 34 - 80 years, were treated for 52 weeks with insulin glargine or NPH insulin given once daily at bedtime.\"\"\",\n",
    "\"\"\"Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol . A total of 50 patients , 17 with primary open angle glaucoma and 33 with capsular glaucoma. Patients were randomised to two treatment groups . No clinically significant side effects were observed during treatment .Latanoprost causes a marked and sustained IOP reduction in eyes which are also being treated with timolol .\"\"\",\n",
    "\"\"\"A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma . This was an observer - masked randomised crossover study of 60 PACG subjects who received either latanoprost or bimatoprost for 6 weeks , after which they were crossed over to the other medication for another 6 weeks . CONCLUSIONS : Bimatoprost once daily was similarly effective in reducing IOP compared with latanoprost once daily in subjects with chronic PACG . Both drugs were well tolerated with mild ocular adverse events .\"\"\",\n",
    "\"\"\"Intraocular pressure - lowering efficacy of brinzolamide when added to travoprost / timolol fixed combination as adjunctive therapy .PURPOSE : To compare the efficacy of brinzolamide versus placebo when added to travoprost / timolol fixed combination ( TTFC ) in uncontrolled patients . This was a prospective , double - masked , randomized , placebo - controlled , parallel comparison of ocular hypertensive or primary open - angle glaucoma patients . Patients treated with a adjunctive therapy were changed to TTFC qam ( every day dosing ) for 4 weeks .Patients were then randomized to either placebo or brinzolamide given twice daily in addition to TTFC . At week 12 , patients had their IOP measurements repeated .This study suggests that brinzolamide may be safely added to TTFC therapy to provide further significant reduction in IOP patients with ocular hypertensive or primary open - angle glaucoma .\"\"\"\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "model_name = \"ner_clinical_trials_abstracts\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "embeddings_clinical download started this may take some time.\n",
      "Approximate size to download 1.6 GB\n",
      "[OK!]\n",
      "ner_clinical_trials_abstracts download started this may take some time.\n",
      "[OK!]\n"
     ]
    }
   ],
   "source": [
    "document_assembler = DocumentAssembler() \\\n",
    "    .setInputCol('text')\\\n",
    "    .setOutputCol('document')\n",
    "\n",
    "sentence_detector = SentenceDetector() \\\n",
    "    .setInputCols(['document'])\\\n",
    "    .setOutputCol('sentence')\n",
    "\n",
    "tokenizer = Tokenizer()\\\n",
    "    .setInputCols(['sentence']) \\\n",
    "    .setOutputCol('token')\n",
    "\n",
    "word_embeddings = WordEmbeddingsModel.pretrained('embeddings_clinical', 'en', 'clinical/models') \\\n",
    "    .setInputCols(['sentence', 'token']) \\\n",
    "    .setOutputCol('embeddings')\n",
    "\n",
    "clinical_ner = MedicalNerModel.pretrained(model_name, \"en\", \"clinical/models\") \\\n",
    "    .setInputCols([\"sentence\", \"token\", \"embeddings\"])\\\n",
    "    .setOutputCol(\"ner\")\n",
    "\n",
    "ner_converter = NerConverter()\\\n",
    "    .setInputCols(['sentence', 'token', 'ner']) \\\n",
    "    .setOutputCol('ner_chunk')\n",
    "\n",
    "nlp_pipeline = Pipeline(stages=[\n",
    "    document_assembler, \n",
    "    sentence_detector,\n",
    "    tokenizer,\n",
    "    word_embeddings,\n",
    "    clinical_ner,\n",
    "    ner_converter\n",
    "    ])\n",
    "\n",
    "empty_df = spark.createDataFrame([['']]).toDF('text')\n",
    "pipeline_model = nlp_pipeline.fit(empty_df)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "+------------------------+------------------+\n",
      "|chunk                   |ner_label         |\n",
      "+------------------------+------------------+\n",
      "|vildagliptin            |Drug              |\n",
      "|type 2 diabetes mellitus|DisorderOrSyndrome|\n",
      "|metformin               |Drug              |\n",
      "|sulphonylurea           |Drug              |\n",
      "|vildagliptin            |Drug              |\n",
      "|metformin               |Drug              |\n",
      "|glimepiride             |Drug              |\n",
      "|type 2 diabetes mellitus|DisorderOrSyndrome|\n",
      "|T2DM                    |DisorderOrSyndrome|\n",
      "|multicentre             |CTDesign          |\n",
      "|double - blind          |CTDesign          |\n",
      "|placebo                 |Drug              |\n",
      "|randomized              |CTDesign          |\n",
      "|vildagliptin            |Drug              |\n",
      "|50                      |DoseValue         |\n",
      "|mg                      |BioAndMedicalUnit |\n",
      "|bid                     |DrugTime          |\n",
      "|placebo                 |Drug              |\n",
      "|24   weeks              |Duration          |\n",
      "|Randomised              |CTDesign          |\n",
      "+------------------------+------------------+\n",
      "only showing top 20 rows\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "df = spark.createDataFrame(pd.DataFrame({'text': text_list}))\n",
    "\n",
    "result = nlpPipeline.fit(df).transform(df)\n",
    "\n",
    "result.select(F.explode(F.arrays_zip(\"ner_chunk.result\", \"ner_chunk.metadata\")).alias(\"cols\"))\\\n",
    "      .select(F.expr(\"cols['0']\").alias(\"chunk\"),\n",
    "              F.expr(\"cols['1']['entity']\").alias(\"ner_label\")).show(truncate=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n",
       "    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n",
       "    \n",
       "    .spark-nlp-display-scroll-entities {\n",
       "        border: 1px solid #E7EDF0;\n",
       "        border-radius: 3px;\n",
       "        text-align: justify;\n",
       "        \n",
       "    }\n",
       "    .spark-nlp-display-scroll-entities span {  \n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #536B76;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-entity-wrapper{\n",
       "    \n",
       "        display: inline-grid;\n",
       "        text-align: center;\n",
       "        border-radius: 4px;\n",
       "        margin: 0 2px 5px 2px;\n",
       "        padding: 1px\n",
       "    }\n",
       "    .spark-nlp-display-entity-name{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        background: #f1f2f3;\n",
       "        border-width: medium;\n",
       "        text-align: center;\n",
       "        \n",
       "        font-weight: 400;\n",
       "        \n",
       "        border-radius: 5px;\n",
       "        padding: 2px 5px;\n",
       "        display: block;\n",
       "        margin: 3px 2px;\n",
       "    \n",
       "    }\n",
       "    .spark-nlp-display-entity-type{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #ffffff;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        text-transform: uppercase;\n",
       "        \n",
       "        font-weight: 500;\n",
       "\n",
       "        display: block;\n",
       "        padding: 3px 5px;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-entity-resolution{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #ffffff;\n",
       "        font-family: 'Vistol Regular', sans-serif !important;\n",
       "        \n",
       "        text-transform: uppercase;\n",
       "        \n",
       "        font-weight: 500;\n",
       "\n",
       "        display: block;\n",
       "        padding: 3px 5px;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-others{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        font-weight: 400;\n",
       "    }\n",
       "\n",
       "</style>\n",
       " <span class=\"spark-nlp-display-others\" style=\"background-color: white\">Efficacy and safety of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">vildagliptin </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in patients with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5FB8A1\"><span class=\"spark-nlp-display-entity-name\">type 2 diabetes mellitus </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> inadequately controlled with dual combination of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">metformin </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">sulphonylurea </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> . This study assessed the efficacy and safety of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">vildagliptin </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> as add - on therapy to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">metformin </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> plus </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">glimepiride </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> combination in patients with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5FB8A1\"><span class=\"spark-nlp-display-entity-name\">type 2 diabetes mellitus </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> ( </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #5FB8A1\"><span class=\"spark-nlp-display-entity-name\">T2DM </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> ) who had inadequate glycaemic control . A </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #664E50\"><span class=\"spark-nlp-display-entity-name\">multicentre </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> , </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #664E50\"><span class=\"spark-nlp-display-entity-name\">double - blind </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> , </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">placebo </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> - controlled study </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #664E50\"><span class=\"spark-nlp-display-entity-name\">randomized </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> patients to receive treatment with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">vildagliptin </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #183FB3\"><span class=\"spark-nlp-display-entity-name\">50 </span><span class=\"spark-nlp-display-entity-type\">DoseValue</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">   </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #90291D\"><span class=\"spark-nlp-display-entity-name\">mg </span><span class=\"spark-nlp-display-entity-type\">BioAndMedicalUnit</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #996F7D\"><span class=\"spark-nlp-display-entity-name\">bid </span><span class=\"spark-nlp-display-entity-type\">DrugTime</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">placebo </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C2202B\"><span class=\"spark-nlp-display-entity-name\">24   weeks </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> .</span></div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n",
       "    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n",
       "    \n",
       "    .spark-nlp-display-scroll-entities {\n",
       "        border: 1px solid #E7EDF0;\n",
       "        border-radius: 3px;\n",
       "        text-align: justify;\n",
       "        \n",
       "    }\n",
       "    .spark-nlp-display-scroll-entities span {  \n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #536B76;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-entity-wrapper{\n",
       "    \n",
       "        display: inline-grid;\n",
       "        text-align: center;\n",
       "        border-radius: 4px;\n",
       "        margin: 0 2px 5px 2px;\n",
       "        padding: 1px\n",
       "    }\n",
       "    .spark-nlp-display-entity-name{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        background: #f1f2f3;\n",
       "        border-width: medium;\n",
       "        text-align: center;\n",
       "        \n",
       "        font-weight: 400;\n",
       "        \n",
       "        border-radius: 5px;\n",
       "        padding: 2px 5px;\n",
       "        display: block;\n",
       "        margin: 3px 2px;\n",
       "    \n",
       "    }\n",
       "    .spark-nlp-display-entity-type{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #ffffff;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        text-transform: uppercase;\n",
       "        \n",
       "        font-weight: 500;\n",
       "\n",
       "        display: block;\n",
       "        padding: 3px 5px;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-entity-resolution{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #ffffff;\n",
       "        font-family: 'Vistol Regular', sans-serif !important;\n",
       "        \n",
       "        text-transform: uppercase;\n",
       "        \n",
       "        font-weight: 500;\n",
       "\n",
       "        display: block;\n",
       "        padding: 3px 5px;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-others{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        font-weight: 400;\n",
       "    }\n",
       "\n",
       "</style>\n",
       " <span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6F0421\"><span class=\"spark-nlp-display-entity-name\">Randomised </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6F0421\"><span class=\"spark-nlp-display-entity-name\">multicentre </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> trial comparing </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">insulin glargine </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">NPH insulin </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in combination with oral agents in patients with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #17AA47\"><span class=\"spark-nlp-display-entity-name\">type 2 diabetes </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. In a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6F0421\"><span class=\"spark-nlp-display-entity-name\">multicentre </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6F0421\"><span class=\"spark-nlp-display-entity-name\">open </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6F0421\"><span class=\"spark-nlp-display-entity-name\">randomised </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> study, </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #84C226\"><span class=\"spark-nlp-display-entity-name\">570 </span><span class=\"spark-nlp-display-entity-type\">NumberPatients</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> patients with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #17AA47\"><span class=\"spark-nlp-display-entity-name\">Type 2 diabetes </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">, aged </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffe0ac\"><span class=\"spark-nlp-display-entity-name\">34 </span><span class=\"spark-nlp-display-entity-type\">Age</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> - </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ffe0ac\"><span class=\"spark-nlp-display-entity-name\">80 </span><span class=\"spark-nlp-display-entity-type\">Age</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> years, were treated for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #559835\"><span class=\"spark-nlp-display-entity-name\">52 weeks </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">insulin glargine </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">NPH insulin </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> given </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #92414A\"><span class=\"spark-nlp-display-entity-name\">once daily </span><span class=\"spark-nlp-display-entity-type\">DrugTime</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> at </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #92414A\"><span class=\"spark-nlp-display-entity-name\">bedtime </span><span class=\"spark-nlp-display-entity-type\">DrugTime</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">.</span></div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n",
       "    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n",
       "    \n",
       "    .spark-nlp-display-scroll-entities {\n",
       "        border: 1px solid #E7EDF0;\n",
       "        border-radius: 3px;\n",
       "        text-align: justify;\n",
       "        \n",
       "    }\n",
       "    .spark-nlp-display-scroll-entities span {  \n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #536B76;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-entity-wrapper{\n",
       "    \n",
       "        display: inline-grid;\n",
       "        text-align: center;\n",
       "        border-radius: 4px;\n",
       "        margin: 0 2px 5px 2px;\n",
       "        padding: 1px\n",
       "    }\n",
       "    .spark-nlp-display-entity-name{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        background: #f1f2f3;\n",
       "        border-width: medium;\n",
       "        text-align: center;\n",
       "        \n",
       "        font-weight: 400;\n",
       "        \n",
       "        border-radius: 5px;\n",
       "        padding: 2px 5px;\n",
       "        display: block;\n",
       "        margin: 3px 2px;\n",
       "    \n",
       "    }\n",
       "    .spark-nlp-display-entity-type{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #ffffff;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        text-transform: uppercase;\n",
       "        \n",
       "        font-weight: 500;\n",
       "\n",
       "        display: block;\n",
       "        padding: 3px 5px;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-entity-resolution{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #ffffff;\n",
       "        font-family: 'Vistol Regular', sans-serif !important;\n",
       "        \n",
       "        text-transform: uppercase;\n",
       "        \n",
       "        font-weight: 500;\n",
       "\n",
       "        display: block;\n",
       "        padding: 3px 5px;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-others{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        font-weight: 400;\n",
       "    }\n",
       "\n",
       "</style>\n",
       " <span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">Latanoprost </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> administered </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6AB620\"><span class=\"spark-nlp-display-entity-name\">once daily </span><span class=\"spark-nlp-display-entity-type\">DrugTime</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> caused a maintained reduction of intraocular pressure in </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #94A59B\"><span class=\"spark-nlp-display-entity-name\">glaucoma </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> patients treated concomitantly with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">timolol </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> . A total of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C7B68F\"><span class=\"spark-nlp-display-entity-name\">50 </span><span class=\"spark-nlp-display-entity-type\">NumberPatients</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> patients , </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C7B68F\"><span class=\"spark-nlp-display-entity-name\">17 </span><span class=\"spark-nlp-display-entity-type\">NumberPatients</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #94A59B\"><span class=\"spark-nlp-display-entity-name\">primary open angle glaucoma </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C7B68F\"><span class=\"spark-nlp-display-entity-name\">33 </span><span class=\"spark-nlp-display-entity-type\">NumberPatients</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #94A59B\"><span class=\"spark-nlp-display-entity-name\">capsular glaucoma </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\">. Patients were </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #ACA82D\"><span class=\"spark-nlp-display-entity-name\">randomised </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to two treatment groups . No clinically significant side effects were observed during treatment .</span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">Latanoprost </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> causes a marked and sustained IOP reduction in eyes which are also being treated with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">timolol </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> .</span></div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n",
       "    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n",
       "    \n",
       "    .spark-nlp-display-scroll-entities {\n",
       "        border: 1px solid #E7EDF0;\n",
       "        border-radius: 3px;\n",
       "        text-align: justify;\n",
       "        \n",
       "    }\n",
       "    .spark-nlp-display-scroll-entities span {  \n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #536B76;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-entity-wrapper{\n",
       "    \n",
       "        display: inline-grid;\n",
       "        text-align: center;\n",
       "        border-radius: 4px;\n",
       "        margin: 0 2px 5px 2px;\n",
       "        padding: 1px\n",
       "    }\n",
       "    .spark-nlp-display-entity-name{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        background: #f1f2f3;\n",
       "        border-width: medium;\n",
       "        text-align: center;\n",
       "        \n",
       "        font-weight: 400;\n",
       "        \n",
       "        border-radius: 5px;\n",
       "        padding: 2px 5px;\n",
       "        display: block;\n",
       "        margin: 3px 2px;\n",
       "    \n",
       "    }\n",
       "    .spark-nlp-display-entity-type{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #ffffff;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        text-transform: uppercase;\n",
       "        \n",
       "        font-weight: 500;\n",
       "\n",
       "        display: block;\n",
       "        padding: 3px 5px;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-entity-resolution{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #ffffff;\n",
       "        font-family: 'Vistol Regular', sans-serif !important;\n",
       "        \n",
       "        text-transform: uppercase;\n",
       "        \n",
       "        font-weight: 500;\n",
       "\n",
       "        display: block;\n",
       "        padding: 3px 5px;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-others{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        font-weight: 400;\n",
       "    }\n",
       "\n",
       "</style>\n",
       " <span class=\"spark-nlp-display-others\" style=\"background-color: white\">A </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6E274F\"><span class=\"spark-nlp-display-entity-name\">randomised crossover </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> study comparing </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">bimatoprost </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> and </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">latanoprost </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in subjects with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #67685D\"><span class=\"spark-nlp-display-entity-name\">primary angle closure glaucoma </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> . This was an </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6E274F\"><span class=\"spark-nlp-display-entity-name\">observer - masked randomised crossover </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> study of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #0F795C\"><span class=\"spark-nlp-display-entity-name\">60 </span><span class=\"spark-nlp-display-entity-type\">NumberPatients</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #67685D\"><span class=\"spark-nlp-display-entity-name\">PACG </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> subjects who received either </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">latanoprost </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">bimatoprost </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B2A439\"><span class=\"spark-nlp-display-entity-name\">6 weeks </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> , after which they were </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #6E274F\"><span class=\"spark-nlp-display-entity-name\">crossed over </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to the other medication for another </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #B2A439\"><span class=\"spark-nlp-display-entity-name\">6 weeks </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> . CONCLUSIONS : </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">Bimatoprost </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3F802E\"><span class=\"spark-nlp-display-entity-name\">once daily </span><span class=\"spark-nlp-display-entity-type\">DrugTime</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> was similarly effective in reducing IOP compared with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">latanoprost </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3F802E\"><span class=\"spark-nlp-display-entity-name\">once daily </span><span class=\"spark-nlp-display-entity-type\">DrugTime</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in subjects with chronic </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #67685D\"><span class=\"spark-nlp-display-entity-name\">PACG </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> . Both drugs were well tolerated with mild ocular adverse events .</span></div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "\n",
       "<style>\n",
       "    @import url('https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&display=swap');\n",
       "    @import url('https://fonts.googleapis.com/css2?family=Vistol Regular:wght@300;400;500;600;700&display=swap');\n",
       "    \n",
       "    .spark-nlp-display-scroll-entities {\n",
       "        border: 1px solid #E7EDF0;\n",
       "        border-radius: 3px;\n",
       "        text-align: justify;\n",
       "        \n",
       "    }\n",
       "    .spark-nlp-display-scroll-entities span {  \n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #536B76;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-entity-wrapper{\n",
       "    \n",
       "        display: inline-grid;\n",
       "        text-align: center;\n",
       "        border-radius: 4px;\n",
       "        margin: 0 2px 5px 2px;\n",
       "        padding: 1px\n",
       "    }\n",
       "    .spark-nlp-display-entity-name{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        background: #f1f2f3;\n",
       "        border-width: medium;\n",
       "        text-align: center;\n",
       "        \n",
       "        font-weight: 400;\n",
       "        \n",
       "        border-radius: 5px;\n",
       "        padding: 2px 5px;\n",
       "        display: block;\n",
       "        margin: 3px 2px;\n",
       "    \n",
       "    }\n",
       "    .spark-nlp-display-entity-type{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #ffffff;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        text-transform: uppercase;\n",
       "        \n",
       "        font-weight: 500;\n",
       "\n",
       "        display: block;\n",
       "        padding: 3px 5px;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-entity-resolution{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        color: #ffffff;\n",
       "        font-family: 'Vistol Regular', sans-serif !important;\n",
       "        \n",
       "        text-transform: uppercase;\n",
       "        \n",
       "        font-weight: 500;\n",
       "\n",
       "        display: block;\n",
       "        padding: 3px 5px;\n",
       "    }\n",
       "    \n",
       "    .spark-nlp-display-others{\n",
       "        font-size: 14px;\n",
       "        line-height: 24px;\n",
       "        font-family: 'Montserrat', sans-serif !important;\n",
       "        \n",
       "        font-weight: 400;\n",
       "    }\n",
       "\n",
       "</style>\n",
       " <span class=\"spark-nlp-display-others\" style=\"background-color: white\">Intraocular pressure - lowering efficacy of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">brinzolamide </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> when added to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">travoprost </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> / </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">timolol </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> fixed combination as adjunctive therapy .PURPOSE : To compare the efficacy of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">brinzolamide </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> versus </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">placebo </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> when added to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">travoprost </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> / </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">timolol </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> fixed combination ( </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">TTFC </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> ) in uncontrolled patients . This was a </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3FA3B9\"><span class=\"spark-nlp-display-entity-name\">prospective </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> , </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3FA3B9\"><span class=\"spark-nlp-display-entity-name\">double - masked </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> , </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3FA3B9\"><span class=\"spark-nlp-display-entity-name\">randomized </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> , </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">placebo </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> - controlled , </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3FA3B9\"><span class=\"spark-nlp-display-entity-name\">parallel </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> comparison of </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9D5982\"><span class=\"spark-nlp-display-entity-name\">ocular hypertensive </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9D5982\"><span class=\"spark-nlp-display-entity-name\">primary open - angle glaucoma </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> patients . Patients treated with a adjunctive therapy were changed to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">TTFC </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1E0A81\"><span class=\"spark-nlp-display-entity-name\">qam </span><span class=\"spark-nlp-display-entity-type\">DrugTime</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> ( </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1E0A81\"><span class=\"spark-nlp-display-entity-name\">every day </span><span class=\"spark-nlp-display-entity-type\">DrugTime</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> dosing ) for </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #C8A356\"><span class=\"spark-nlp-display-entity-name\">4 weeks </span><span class=\"spark-nlp-display-entity-type\">Duration</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> .Patients were then </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #3FA3B9\"><span class=\"spark-nlp-display-entity-name\">randomized </span><span class=\"spark-nlp-display-entity-type\">CTDesign</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> to either </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">placebo </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">brinzolamide </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> given </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #1E0A81\"><span class=\"spark-nlp-display-entity-name\">twice daily </span><span class=\"spark-nlp-display-entity-type\">DrugTime</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> in addition to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">TTFC </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> . At </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #4E9B9C\"><span class=\"spark-nlp-display-entity-name\">week 12 </span><span class=\"spark-nlp-display-entity-type\">TimePoint</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> , patients had their IOP measurements repeated .This study suggests that </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">brinzolamide </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> may be safely added to </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #8B668B\"><span class=\"spark-nlp-display-entity-name\">TTFC </span><span class=\"spark-nlp-display-entity-type\">Drug</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> therapy to provide further significant reduction in IOP patients with </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9D5982\"><span class=\"spark-nlp-display-entity-name\">ocular hypertensive </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> or </span><span class=\"spark-nlp-display-entity-wrapper\" style=\"background-color: #9D5982\"><span class=\"spark-nlp-display-entity-name\">primary open - angle glaucoma </span><span class=\"spark-nlp-display-entity-type\">DisorderOrSyndrome</span></span><span class=\"spark-nlp-display-others\" style=\"background-color: white\"> .</span></div>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "from sparknlp_display import NerVisualizer\n",
    "\n",
    "visualiser = NerVisualizer()\n",
    "\n",
    "for i in range(len(text_list)):\n",
    "  visualiser.display(result = result.collect()[i] ,label_col = 'ner_chunk', document_col = 'document')\n",
    "  print(\"\\n\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Creating inputs folders\n",
    "\n",
    "INPUT_FILE_PATH = f\"../inputs/{model_name}/\"\n",
    "\n",
    "!rm -r $INPUT_FILE_PATH\n",
    "!mkdir -p $INPUT_FILE_PATH\n",
    "\n",
    "for i, v in enumerate(text_list):\n",
    "    open(os.path.join(INPUT_FILE_PATH, f\"Example{i+1}.txt\"), \"w\", encoding=\"utf8\").write(v[:v.find(\"\\n\")] + \"\\n\"+ v)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Creating output folders\n",
    "\n",
    "OUTPUT_FILE_PATH = f\"../outputs/{model_name}\"\n",
    "\n",
    "!rm -r $OUTPUT_FILE_PATH\n",
    "!mkdir -p $OUTPUT_FILE_PATH"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [],
   "source": [
    "file_list=sorted(os.listdir(INPUT_FILE_PATH))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {},
   "outputs": [],
   "source": [
    "result = result.toPandas()\n",
    "\n",
    "for i in result.index:\n",
    "    result[['ner_chunk']].iloc[i].to_json(\n",
    "        os.path.join(OUTPUT_FILE_PATH, file_list[i].split('.')[0]+\".json\"))"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3.6.10 ('tensorflow_p36')",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.10"
  },
  "orig_nbformat": 4,
  "vscode": {
   "interpreter": {
    "hash": "60af5c81ffa00bed911704ff054405489da13f9503e86373e95cf9267d593cbf"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
